Plain-English translation of NCT05802849 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial tests whether , a type of water pill, can help reduce swelling and fluid buildup better than the standard heart failure medications currently used. Heart failure makes it hard for your heart to pump effectively, causing fluid to build up in your body and leading to swelling, shortness of breath, and fatigue. Researchers want to see if this medication can help you feel better faster during a hospital stay.
Heart failure patients often need hospitalization because of dangerous fluid buildup in their bodies. Doctors want to find better ways to remove this extra fluid and reduce symptoms, so they're testing whether this medication could work more effectively than current standard treatments.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly placed in one of two groups: one group receives three times daily (250 mg per dose), and the other receives standard heart failure medications. Both groups are hospitalized and monitored by the medical team. The study tracks how well your swelling improves, your symptoms get better, and how your body responds to the treatment during your hospital stay.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Russia